The Export Control (Amendment) Order 2012
Citation and commencement1.
This Order may be cited as the Export Control (Amendment) Order 2012 and comes into force on 16th April 2012.
Revocation2.
Amendments to the Export Control Order 20083.
(1)
(2)
“Movement of certain medicinal products to the United States of America4A.
(1)
Subject to articles 17 and 26, no person shall export a human or veterinary medicinal product containing the active ingredient pancuronium bromide where—
(a)
the product is in a form suitable for injection or for preparation of an injection; and
(b)
paragraph (2) or (3) applies.
(2)
This paragraph applies where the destination of the product is the United States of America.
(3)
This paragraph applies where the destination is not the United States of America but the exporter knows that the final destination of the product is the United States of America.”.
(3)
In article 17 (transit or transhipment exception), in paragraph (1) after “4,” insert “4A,”.
(4)
In article 41 (application of CEMA in respect of offences), in each of paragraphs (1)(a)(i) and (2)(a) after “4,” insert “4A,”.
This Order amends the Export Control Order 2008 (S.I. 2008/3231) to insert article 4A to prohibit the export of human and veterinary medicinal products containing pancuronium bromide. The prohibition only applies to the export of these products where they are in a form suitable for injection or for preparation of an injection and the final destination is the United States of America.
It also revokes the Export Control (Amendment) (No.3) Order 2011 (S.I. 2011/1127) which is spent.
A regulatory impact assessment has not been prepared for this instrument as it has no or minimal impact on business, charities or voluntary bodies. An Explanatory Memorandum is published alongside the instrument on www.legislation.gov.uk.